Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C477931 |
1L-6-hydroxymethyl-chiro-inositol 2(R)-2-O-methyl-3-O-octadecylcarbonate |
1L-6-hydroxymethyl-chiro-inositol 2(R)-2-O-methyl-3-O-octadecylcarbonate inhibits the reaction [Tretinoin results in increased activity of STS protein] | decreases reaction|increases activity | 16178010
|
C085911 |
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one |
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Tretinoin results in increased activity of STS protein] | decreases reaction|increases activity | 16178010
|
C023514 |
2,6-dinitrotoluene |
2,6-dinitrotoluene affects the expression of STS mRNA | affects expression | 21346803
|
C500344 |
2-methoxyestradiol-3,17-bis-O,O-sulfamate |
2-methoxyestradiol-3,17-bis-O,O-sulfamate analog results in decreased activity of STS protein | decreases activity | 15862969
|
C500344 |
2-methoxyestradiol-3,17-bis-O,O-sulfamate |
2-methoxyestradiol-3,17-bis-O,O-sulfamate results in decreased activity of STS protein | decreases activity | 14623540 15862969 12711022
|
C526438 |
2-methoxyestradiol-3,17-O,O-bis(sulfamate) |
2-methoxyestradiol-3,17-O,O-bis(sulfamate) results in decreased activity of STS protein | decreases activity | 18450955
|
C041525 |
3,3',4,5'-tetrahydroxystilbene |
3,3',4,5'-tetrahydroxystilbene inhibits the reaction [Tretinoin results in increased activity of STS protein] | decreases reaction|increases activity | 16178010
|
C038864 |
4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid |
4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid results in increased activity of STS protein | increases activity | 16178010
|
C038864 |
4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid |
AGN 194310 inhibits the reaction [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid results in increased activity of STS protein] | decreases reaction|increases activity | 16178010
|
C038864 |
4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid |
wortmannin inhibits the reaction [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid results in increased activity of STS protein] | decreases reaction|increases activity | 16178010
|
C021228 |
4-nitrocatechol sulfate |
4-nitrocatechol sulfate results in decreased activity of STS protein | decreases activity | 6874424
|
C023379 |
4-nitrophenyl sulfate |
4-nitrophenyl sulfate results in decreased activity of STS protein | decreases activity | 6874424
|
C489251 |
5-iodo-3-((3,5-dibromo-4-hydroxyphenyl)methylene)-2-indolinone |
5-iodo-3-((3,5-dibromo-4-hydroxyphenyl)methylene)-2-indolinone inhibits the reaction [Tretinoin results in increased activity of STS protein] | decreases reaction|increases activity | 16178010
|
C412043 |
667 coumate |
667 coumate results in decreased activity of STS protein | decreases activity | 12711022 14623540
|
C054852 |
7-hydroxystaurosporine |
7-hydroxystaurosporine inhibits the reaction [Tretinoin results in increased activity of STS protein] | decreases reaction|increases activity | 16178010
|
D000082 |
Acetaminophen |
Acetaminophen affects the expression of STS mRNA | affects expression | 17562736
|
C412373 |
AG 1879 |
AG 1879 inhibits the reaction [Tretinoin results in increased activity of STS protein] | decreases reaction|increases activity | 16178010
|
C090766 |
AGN 190299 |
AGN 190299 results in increased activity of STS protein | increases activity | 16178010
|
C121616 |
AGN 194310 |
AGN 194310 inhibits the reaction [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid results in increased activity of STS protein] | decreases reaction|increases activity | 16178010
|
C121616 |
AGN 194310 |
AGN 194310 inhibits the reaction [AGN 195183 results in increased activity of STS protein] | decreases reaction|increases activity | 16178010
|
C121616 |
AGN 194310 |
AGN 194310 inhibits the reaction [Tretinoin results in increased activity of STS protein] | decreases reaction|increases activity | 16178010
|
C492393 |
AGN 195183 |
AGN 194310 inhibits the reaction [AGN 195183 results in increased activity of STS protein] | decreases reaction|increases activity | 16178010
|
C492393 |
AGN 195183 |
AGN 195183 results in increased activity of STS protein | increases activity | 16178010
|
C492393 |
AGN 195183 |
wortmannin inhibits the reaction [AGN 195183 results in increased activity of STS protein] | decreases reaction|increases activity | 16178010
|
C103303 |
alitretinoin |
alitretinoin results in increased activity of STS protein | increases activity | 16178010
|
C068073 |
Am 580 |
Am 580 results in increased activity of STS protein | increases activity | 16178010
|
D000643 |
Ammonium Chloride |
Ammonium Chloride affects the expression of STS mRNA | affects expression | 16483693
|
C072553 |
benzyloxycarbonylleucyl-leucyl-leucine aldehyde |
benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [Tretinoin results in increased activity of STS protein] | decreases reaction|increases activity | 16178010
|
C070515 |
bisindolylmaleimide I |
bisindolylmaleimide I inhibits the reaction [Tretinoin results in increased activity of STS protein] | decreases reaction|increases activity | 16178010
|
C002791 |
bismuth tripotassium dicitrate |
bismuth tripotassium dicitrate results in increased expression of STS mRNA | increases expression | 15912405
|
C059975 |
bistratene A |
[Tretinoin co-treated with bistratene A] results in increased activity of STS protein | affects cotreatment|increases activity | 16178010
|
D020001 |
1-Butanol |
1-Butanol inhibits the reaction [Tretinoin results in increased activity of STS protein] | decreases reaction|increases activity | 16178010
|
D002330 |
Carmustine |
Carmustine results in increased expression of STS mRNA | increases expression | 15980968
|
C105934 |
celecoxib |
celecoxib inhibits the reaction [Tretinoin results in increased activity of STS protein] | decreases reaction|increases activity | 16178010
|
D002746 |
Chlorpromazine |
Chlorpromazine inhibits the reaction [Tretinoin results in increased activity of STS protein] | decreases reaction|increases activity | 16178010
|
D003474 |
Curcumin |
Curcumin results in decreased expression of STS mRNA | decreases expression | 17198877
|
D016572 |
Cyclosporine |
Cyclosporine results in decreased expression of STS mRNA | decreases expression | 20106945
|
C107676 |
deguelin |
deguelin inhibits the reaction [Tretinoin results in increased activity of STS protein] | decreases reaction|increases activity | 16178010
|
D003687 |
Dehydroepiandrosterone |
STS protein results in increased chemical synthesis of Dehydroepiandrosterone | increases chemical synthesis | 16054388
|
D019314 |
Dehydroepiandrosterone Sulfate |
STS protein affects the metabolism of Dehydroepiandrosterone Sulfate | affects metabolic processing | 16054388
|
C121718 |
dicyclanil |
dicyclanil results in decreased expression of STS mRNA | decreases expression | 15664270
|
D019794 |
2,3-Diphosphoglycerate |
2,3-Diphosphoglycerate inhibits the reaction [Tretinoin results in increased activity of STS protein] | decreases reaction|increases activity | 16178010
|
D004855 |
Equilenin |
STS protein results in increased metabolism of Equilenin | increases metabolic processing | 6874424
|
D004970 |
Estrone |
STS protein results in increased chemical synthesis of Estrone | increases chemical synthesis | 16054388
|
C088768 |
estrone-3-O-sulfamate |
estrone-3-O-sulfamate results in decreased activity of STS protein | decreases activity | 12711022
|
C017296 |
estrone sulfate |
STS protein affects the metabolism of estrone sulfate | affects metabolic processing | 16054388
|
C081021 |
Go 6976 |
Go 6976 inhibits the reaction [Tretinoin results in increased activity of STS protein] | decreases reaction|increases activity | 16178010
|
C475919 |
hydroxytamoxifen |
hydroxytamoxifen results in decreased expression of STS mRNA | decreases expression | 16849584
|
C064769 |
N-acetylsphingosine |
N-acetylsphingosine inhibits the reaction [Tretinoin results in increased activity of STS protein] | decreases reaction|increases activity | 16178010
|
C002669 |
parthenolide |
parthenolide inhibits the reaction [Tretinoin results in increased activity of STS protein] | decreases reaction|increases activity | 16178010
|
C093973 |
PD 98059 |
PD 98059 inhibits the reaction [Tretinoin results in increased activity of STS protein] | decreases reaction|increases activity | 16178010
|
D010710 |
Phosphates |
Phosphates results in decreased activity of STS protein | decreases activity | 6874424
|
D010712 |
Phosphatidic Acids |
Phosphatidic Acids promotes the reaction [Tretinoin results in increased activity of STS protein] | increases activity|increases reaction | 16178010
|
C006253 |
pirinixic acid |
pirinixic acid results in decreased expression of STS mRNA | decreases expression | 20059764
|
C006253 |
pirinixic acid |
PPARA protein promotes the reaction [pirinixic acid results in decreased expression of STS mRNA] | decreases expression|increases reaction | 20059764
|
D011433 |
Propranolol |
Propranolol inhibits the reaction [Tretinoin results in increased activity of STS protein] | decreases reaction|increases activity | 16178010
|
C085746 |
rottlerin |
rottlerin inhibits the reaction [Tretinoin results in increased activity of STS protein] | decreases reaction|increases activity | 16178010
|
D020123 |
Sirolimus |
Sirolimus inhibits the reaction [Tretinoin results in increased activity of STS protein] | decreases reaction|increases activity | 16178010
|
C118258 |
SN50 peptide |
SN50 peptide inhibits the reaction [Tretinoin results in increased activity of STS protein] | decreases reaction|increases activity | 16178010
|
C010634 |
sodium borate |
sodium borate results in decreased activity of STS protein | decreases activity | 6874424
|
C515227 |
STX 213 |
STX 213 results in decreased activity of STS protein | decreases activity | 18450955
|
C520511 |
STX64 compound |
STX64 compound results in decreased activity of STS protein | decreases activity | 18450955
|
C086827 |
tazarotene |
tazarotene metabolite results in increased activity of STS protein | increases activity | 16178010
|
C086827 |
tazarotene |
tazarotene results in increased activity of STS protein | increases activity | 16178010
|
C086827 |
tazarotene |
wortmannin inhibits the reaction [tazarotene results in increased activity of STS protein] | decreases reaction|increases activity | 16178010
|
D014108 |
Tosylphenylalanyl Chloromethyl Ketone |
Tosylphenylalanyl Chloromethyl Ketone inhibits the reaction [Tretinoin results in increased activity of STS protein] | decreases reaction|increases activity | 16178010
|
D014212 |
Tretinoin |
1-Butanol inhibits the reaction [Tretinoin results in increased activity of STS protein] | decreases reaction|increases activity | 16178010
|
D014212 |
Tretinoin |
1L-6-hydroxymethyl-chiro-inositol 2(R)-2-O-methyl-3-O-octadecylcarbonate inhibits the reaction [Tretinoin results in increased activity of STS protein] | decreases reaction|increases activity | 16178010
|
D014212 |
Tretinoin |
2,3-Diphosphoglycerate inhibits the reaction [Tretinoin results in increased activity of STS protein] | decreases reaction|increases activity | 16178010
|
D014212 |
Tretinoin |
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Tretinoin results in increased activity of STS protein] | decreases reaction|increases activity | 16178010
|
D014212 |
Tretinoin |
3,3',4,5'-tetrahydroxystilbene inhibits the reaction [Tretinoin results in increased activity of STS protein] | decreases reaction|increases activity | 16178010
|
D014212 |
Tretinoin |
5-iodo-3-((3,5-dibromo-4-hydroxyphenyl)methylene)-2-indolinone inhibits the reaction [Tretinoin results in increased activity of STS protein] | decreases reaction|increases activity | 16178010
|
D014212 |
Tretinoin |
7-hydroxystaurosporine inhibits the reaction [Tretinoin results in increased activity of STS protein] | decreases reaction|increases activity | 16178010
|
D014212 |
Tretinoin |
AG 1879 inhibits the reaction [Tretinoin results in increased activity of STS protein] | decreases reaction|increases activity | 16178010
|
D014212 |
Tretinoin |
AGN 194310 inhibits the reaction [Tretinoin results in increased activity of STS protein] | decreases reaction|increases activity | 16178010
|
D014212 |
Tretinoin |
benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [Tretinoin results in increased activity of STS protein] | decreases reaction|increases activity | 16178010
|
D014212 |
Tretinoin |
bisindolylmaleimide I inhibits the reaction [Tretinoin results in increased activity of STS protein] | decreases reaction|increases activity | 16178010
|
D014212 |
Tretinoin |
celecoxib inhibits the reaction [Tretinoin results in increased activity of STS protein] | decreases reaction|increases activity | 16178010
|
D014212 |
Tretinoin |
Chlorpromazine inhibits the reaction [Tretinoin results in increased activity of STS protein] | decreases reaction|increases activity | 16178010
|
D014212 |
Tretinoin |
deguelin inhibits the reaction [Tretinoin results in increased activity of STS protein] | decreases reaction|increases activity | 16178010
|
D014212 |
Tretinoin |
Go 6976 inhibits the reaction [Tretinoin results in increased activity of STS protein] | decreases reaction|increases activity | 16178010
|
D014212 |
Tretinoin |
N-acetylsphingosine inhibits the reaction [Tretinoin results in increased activity of STS protein] | decreases reaction|increases activity | 16178010
|
D014212 |
Tretinoin |
parthenolide inhibits the reaction [Tretinoin results in increased activity of STS protein] | decreases reaction|increases activity | 16178010
|
D014212 |
Tretinoin |
PD 98059 inhibits the reaction [Tretinoin results in increased activity of STS protein] | decreases reaction|increases activity | 16178010
|
D014212 |
Tretinoin |
Phosphatidic Acids promotes the reaction [Tretinoin results in increased activity of STS protein] | increases activity|increases reaction | 16178010
|
D014212 |
Tretinoin |
PRKCA protein affects the reaction [Tretinoin results in increased activity of STS protein] | affects reaction|increases activity | 16178010
|
D014212 |
Tretinoin |
PRKCD protein affects the reaction [Tretinoin results in increased activity of STS protein] | affects reaction|increases activity | 16178010
|
D014212 |
Tretinoin |
Propranolol inhibits the reaction [Tretinoin results in increased activity of STS protein] | decreases reaction|increases activity | 16178010
|
D014212 |
Tretinoin |
RARA protein promotes the reaction [Tretinoin results in increased activity of STS protein] | increases activity|increases reaction | 16178010
|
D014212 |
Tretinoin |
rottlerin inhibits the reaction [Tretinoin results in increased activity of STS protein] | decreases reaction|increases activity | 16178010
|
D014212 |
Tretinoin |
Sirolimus inhibits the reaction [Tretinoin results in increased activity of STS protein] | decreases reaction|increases activity | 16178010
|
D014212 |
Tretinoin |
SN50 peptide inhibits the reaction [Tretinoin results in increased activity of STS protein] | decreases reaction|increases activity | 16178010
|
D014212 |
Tretinoin |
Tosylphenylalanyl Chloromethyl Ketone inhibits the reaction [Tretinoin results in increased activity of STS protein] | decreases reaction|increases activity | 16178010
|
D014212 |
Tretinoin |
[Tretinoin co-treated with bistratene A] results in increased activity of STS protein | affects cotreatment|increases activity | 16178010
|
D014212 |
Tretinoin |
Tretinoin results in increased activity of STS protein | increases activity | 16178010
|
D014212 |
Tretinoin |
U 0126 inhibits the reaction [Tretinoin results in increased activity of STS protein] | decreases reaction|increases activity | 16178010
|
D014212 |
Tretinoin |
wortmannin inhibits the reaction [Tretinoin results in increased activity of STS protein] | decreases reaction|increases activity | 16178010
|
C113580 |
U 0126 |
U 0126 inhibits the reaction [Tretinoin results in increased activity of STS protein] | decreases reaction|increases activity | 16178010
|
C009687 |
wortmannin |
wortmannin inhibits the reaction [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid results in increased activity of STS protein] | decreases reaction|increases activity | 16178010
|
C009687 |
wortmannin |
wortmannin inhibits the reaction [AGN 195183 results in increased activity of STS protein] | decreases reaction|increases activity | 16178010
|
C009687 |
wortmannin |
wortmannin inhibits the reaction [tazarotene results in increased activity of STS protein] | decreases reaction|increases activity | 16178010
|
C009687 |
wortmannin |
wortmannin inhibits the reaction [Tretinoin results in increased activity of STS protein] | decreases reaction|increases activity | 16178010
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
2.95 | 18287403 |
MESH:D000168 |
Acrocephalosyndactylia |
|
U 0126 |
4.88 | 17694057 |
MESH:D055371 |
Acute Lung Injury |
|
pirinixic acid |
2.56 | 18653653 |
MESH:D018248 |
Adenoma, Liver Cell |
|
dicyclanil |
8.51 | 17162532 |
MESH:D018248 |
Adenoma, Liver Cell |
|
pirinixic acid |
8.51 | 16434500 |
MESH:D011125 |
Adenomatous Polyposis Coli |
|
celecoxib |
4.55 | 16215675 19003578 |
MESH:D000309 |
Adrenal Insufficiency |
|
Dehydroepiandrosterone |
5.17 | 17302879 |
MESH:D019973 |
Alcohol-Related Disorders |
|
Curcumin |
4.46 | 17887948 |
MESH:D000505 |
Alopecia |
|
Tretinoin |
3.12 | 15955085 |
MESH:D000544 |
Alzheimer Disease |
|
Curcumin |
2.46 | 15590663 |
MESH:D000799 |
Angioedema |
|
Acetaminophen |
3.22 | 10982225 |
MESH:D001169 |
Arthritis, Experimental |
|
Tosylphenylalanyl Chloromethyl Ketone |
6.65 | 18706406 |
MESH:D001169 |
Arthritis, Experimental |
|
Tretinoin |
6.65 | 16412693 |
MESH:D001172 |
Arthritis, Rheumatoid |
|
Curcumin |
4.11 | 16807698 |
MESH:D001172 |
Arthritis, Rheumatoid |
|
Tretinoin |
4.11 | 16292516 |
MESH:D001249 |
Asthma |
|
Tretinoin |
2.13 | 16456186 |
MESH:D001259 |
Ataxia |
|
1-Butanol |
5.02 | 7820390 |
MESH:D050197 |
Atherosclerosis |
|
Curcumin |
2.94 | 18704882 |
MESH:D001289 |
Attention Deficit Disorder with Hyperactivity |
marker/mechanism |
|
| 18413370 |
MESH:D001321 |
Autistic Disorder |
|
Acetaminophen |
2.61 | 18445737 |
MESH:D001321 |
Autistic Disorder |
|
Dehydroepiandrosterone Sulfate |
2.61 | 15820420 |
MESH:D001321 |
Autistic Disorder |
|
Propranolol |
2.61 | 18766980 |
MESH:D001321 |
Autistic Disorder |
|
Sirolimus |
2.61 | 21115397 |
MESH:D001327 |
Autoimmune Diseases |
|
Curcumin |
3.90 | 19761891 |
MESH:D001471 |
Barrett Esophagus |
|
Tretinoin |
3.82 | 16935849 |
MESH:D001778 |
Blood Coagulation Disorders |
|
pirinixic acid |
7.16 | 19483382 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tretinoin |
7.16 | 16206674 16197459 |
MESH:D001919 |
Bradycardia |
|
Propranolol |
4.96 | 6740701 |
MESH:D002545 |
Brain Ischemia |
|
Curcumin |
3.73 | 16770732 |
MESH:D001932 |
Brain Neoplasms |
|
Carmustine |
7.41 | 16187019 |
MESH:D001932 |
Brain Neoplasms |
|
Curcumin |
7.41 | 17596214 |
MESH:D001943 |
Breast Neoplasms |
|
2-methoxyestradiol-3,17-bis-O,O-sulfamate |
4.05 | 17957467 12711013 12711022 17426705 15862969 14970876 |
MESH:D001943 |
Breast Neoplasms |
|
2-methoxyestradiol-3,17-O,O-bis(sulfamate) |
4.05 | 18223236 18985042 18506995 18026194 |
MESH:D001943 |
Breast Neoplasms |
|
alitretinoin |
4.05 | 16344269 |
MESH:D001943 |
Breast Neoplasms |
|
Curcumin |
4.05 | 18462866 19250217 16243823 18593918 |
MESH:D001943 |
Breast Neoplasms |
|
deguelin |
4.05 | 17035597 18593368 |
MESH:D001943 |
Breast Neoplasms |
|
estrone sulfate |
4.05 | 17261762 |
MESH:D001943 |
Breast Neoplasms |
|
parthenolide |
4.05 | 16873071 |
MESH:D001943 |
Breast Neoplasms |
|
Tretinoin |
4.05 | 16443354 16166294 16873071 |
MESH:D001997 |
Bronchopulmonary Dysplasia |
|
Tretinoin |
3.98 | 16813970 |
MESH:D002277 |
Carcinoma |
|
Curcumin |
3.35 | 18593918 |
MESH:D018236 |
Carcinoma, Embryonal |
|
Tretinoin |
4.54 | 16168501 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
2,6-dinitrotoluene |
9.64 | 16705839 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Acetaminophen |
9.64 | 3084413 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
deguelin |
9.64 | 18575727 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
dicyclanil |
9.64 | 17162532 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Sirolimus |
9.64 | 19335982 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Tretinoin |
9.64 | 1917145 |
MESH:D002289 |
Carcinoma, Non-Small-Cell Lung |
|
Curcumin |
2.74 | 18414057 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
celecoxib |
3.87 | 16369983 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Curcumin |
6.46 | 18462866 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Sirolimus |
6.46 | 19435901 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Tretinoin |
6.46 | 16051514 16096774 |
MESH:D002386 |
Cataract |
|
Acetaminophen |
10.22 | 10977129 |
MESH:D002386 |
Cataract |
|
Am 580 |
10.22 | 17460283 |
MESH:D002386 |
Cataract |
|
Tretinoin |
10.22 | 17460283 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
2,6-dinitrotoluene |
5.13 | 6135515 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Cyclosporine |
5.13 | 12371664 |
MESH:D018290 |
Cervical Intraepithelial Neoplasia |
|
Tretinoin |
3.98 | 16129372 |
MESH:D002779 |
Cholestasis |
|
Cyclosporine |
6.21 | 19486331 |
MESH:D002779 |
Cholestasis |
|
pirinixic acid |
6.21 | 19176532 |
MESH:D002822 |
Choriocarcinoma |
|
Tretinoin |
4.54 | 16461808 |
MESH:D002972 |
Cleft Palate |
|
Tretinoin |
2.38 | 9407595 |
MESH:D003092 |
Colitis |
|
Am 580 |
12.78 | 17035595 |
MESH:D003092 |
Colitis |
|
Curcumin |
12.78 | 16782535 18200517 16804969 |
MESH:D003092 |
Colitis |
|
Tretinoin |
12.78 | 17035595 |
MESH:D003103 |
Coloboma |
|
Curcumin |
4.00 | 18809619 |
MESH:D003110 |
Colonic Neoplasms |
|
celecoxib |
3.87 | 16004971 |
MESH:D003110 |
Colonic Neoplasms |
|
Curcumin |
3.87 | 19359593 16340194 |
MESH:D015179 |
Colorectal Neoplasms |
|
celecoxib |
3.16 | 11197048 18349538 |
MESH:D016510 |
Corneal Neovascularization |
|
Curcumin |
4.30 | 18497527 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tretinoin |
1.79 | 16925845 9224671 17551590 9142499 9125849 9211117 14991402 9664655 8800419 10589399 |
MESH:D003490 |
Cyanosis |
|
2,6-dinitrotoluene |
3.42 | 18551238 |
MESH:D003876 |
Dermatitis, Atopic |
|
pirinixic acid |
2.11 | 18249437 |
MESH:D003922 |
Diabetes Mellitus, Type 1 |
|
Dehydroepiandrosterone |
3.48 | 16616286 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Curcumin |
2.53 | 18403477 |
MESH:D003928 |
Diabetic Nephropathies |
|
Curcumin |
3.49 | 18204486 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
2,6-dinitrotoluene |
5.11 | 21346803 18551238 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Acetaminophen |
5.11 | 11743745 19923254 18071297 11834606 19416960 16227642 10915739 12958197 10774834 2444490 19164858 17522070 19739265 16081117 12153990 17562736 11461765 16485898 14550746 14725611 11529661 16393943 11739529 19085960 19420014 16109766 15619225 16781746 10663392 15968718 12705907 16177239 11287661 14986274 18713872 11421492 17906064 19370779 12540782 12594235 12392966 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Chlorpromazine |
5.11 | 11461765 |
MESH:D056487 |
Drug-Induced Liver Injury, Chronic |
|
Acetaminophen |
3.48 | 19426721 |
MESH:D004381 |
Duodenal Ulcer |
|
Curcumin |
3.48 | 17351913 |
MESH:D004487 |
Edema |
|
bisindolylmaleimide I |
5.52 | 8273558 |
MESH:D004487 |
Edema |
|
pirinixic acid |
5.52 | 12083418 |
MESH:D004489 |
Edema, Cardiac |
|
Tretinoin |
3.85 | 18230668 |
MESH:D016889 |
Endometrial Neoplasms |
|
2-methoxyestradiol-3,17-O,O-bis(sulfamate) |
14.74 | 18450955 |
MESH:D016889 |
Endometrial Neoplasms |
|
STX 213 |
14.74 | 18450955 |
MESH:D016889 |
Endometrial Neoplasms |
|
STX64 compound |
14.74 | 18450955 |
MESH:D016889 |
Endometrial Neoplasms |
|
Tretinoin |
14.74 | 16569247 |
MESH:D004715 |
Endometriosis |
|
celecoxib |
4.43 | 15652904 |
MESH:D005124 |
Eye Abnormalities |
|
Tretinoin |
3.11 | 9664655 16938888 |
MESH:D005234 |
Fatty Liver |
|
Curcumin |
9.98 | 19297423 |
MESH:D005234 |
Fatty Liver |
|
Cyclosporine |
9.98 | 19224547 |
MESH:D005234 |
Fatty Liver |
|
pirinixic acid |
9.98 | 20131406 19236843 |
MESH:D005355 |
Fibrosis |
|
Curcumin |
11.44 | 18705752 |
MESH:D005355 |
Fibrosis |
|
Cyclosporine |
11.44 | 12639820 12168785 |
MESH:D005355 |
Fibrosis |
|
Tretinoin |
11.44 | 17994277 |
MESH:D005756 |
Gastritis |
|
Acetaminophen |
3.06 | 16983495 |
MESH:D005770 |
Gastrointestinal Neoplasms |
|
Curcumin |
4.10 | 18462866 |
MESH:D005885 |
Gingival Hyperplasia |
|
Cyclosporine |
3.61 | 8708960 |
MESH:D005909 |
Glioblastoma |
|
Carmustine |
9.60 | 16187019 |
MESH:D005909 |
Glioblastoma |
|
Curcumin |
9.60 | 17596214 |
MESH:D005909 |
Glioblastoma |
|
Tretinoin |
9.60 | 17312396 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Curcumin |
10.64 | 18829502 18462866 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Sirolimus |
10.64 | 19435901 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Tretinoin |
10.64 | 16096774 |
MESH:D006317 |
Hearing Loss, Noise-Induced |
|
Tretinoin |
4.54 | 16084493 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tretinoin |
2.55 | 9664655 14991402 |
MESH:D006333 |
Heart Failure |
|
pirinixic acid |
6.18 | 20558911 |
MESH:D006333 |
Heart Failure |
|
Propranolol |
6.18 | 20082655 |
MESH:D006457 |
Hemoglobinuria, Paroxysmal |
|
Cyclosporine |
3.81 | 15720958 |
MESH:D006529 |
Hepatomegaly |
|
pirinixic acid |
7.11 | 19176532 19772884 16221962 18467677 |
MESH:D006529 |
Hepatomegaly |
|
Propranolol |
7.11 | 16371745 |
MESH:D015417 |
Hereditary Sensory and Motor Neuropathy |
|
Curcumin |
4.44 | 17701891 |
MESH:D006561 |
Herpes Simplex |
|
Chlorpromazine |
4.69 | 1682908 |
MESH:D006930 |
Hyperalgesia |
|
Acetaminophen |
6.01 | 16870215 |
MESH:D006930 |
Hyperalgesia |
|
Tretinoin |
6.01 | 16870215 |
MESH:D017588 |
Hyperandrogenism |
|
Dehydroepiandrosterone Sulfate |
5.92 | 17392600 |
MESH:D006937 |
Hypercholesterolemia |
|
Curcumin |
3.51 | 18704882 |
MESH:D017681 |
Hypereosinophilic Syndrome |
|
Tretinoin |
3.97 | 16778211 |
MESH:D006943 |
Hyperglycemia |
|
pirinixic acid |
2.65 | 20558911 |
MESH:D006973 |
Hypertension |
|
Cyclosporine |
1.84 | 10903974 |
MESH:D006984 |
Hypertrophy |
|
Sirolimus |
4.68 | 19211884 |
MESH:D007022 |
Hypotension |
|
Propranolol |
4.62 | 6740701 |
MESH:D016114 |
Ichthyosis, X-Linked |
marker/mechanism |
|
| |
MESH:D007249 |
Inflammation |
|
bisindolylmaleimide I |
4.70 | 8273558 |
MESH:D007249 |
Inflammation |
|
Curcumin |
4.70 | 16956363 17151092 18403477 |
MESH:D015212 |
Inflammatory Bowel Diseases |
|
Curcumin |
2.93 | 18200517 18596194 |
MESH:D007333 |
Insulin Resistance |
|
pirinixic acid |
2.22 | 16306350 |
MESH:D007410 |
Intestinal Diseases |
|
Tretinoin |
3.18 | 17994277 |
MESH:D007414 |
Intestinal Neoplasms |
|
Curcumin |
3.69 | 10783313 |
MESH:D007569 |
Jaw Abnormalities |
|
Tretinoin |
3.35 | 15992940 17551590 |
MESH:D007638 |
Keratoconjunctivitis Sicca |
|
Cyclosporine |
3.82 | 15604871 |
MESH:D017492 |
Keratosis, Seborrheic |
|
alitretinoin |
5.03 | 16144296 |
MESH:D007674 |
Kidney Diseases |
|
Acetaminophen |
4.54 | 15629191 12587719 |
MESH:D007674 |
Kidney Diseases |
|
Cyclosporine |
4.54 | 8314463 18776723 10903974 |
MESH:D007680 |
Kidney Neoplasms |
|
2,6-dinitrotoluene |
9.72 | 16705839 |
MESH:D007680 |
Kidney Neoplasms |
|
Cyclosporine |
9.72 | 12371664 |
MESH:D007680 |
Kidney Neoplasms |
|
Estrone |
9.72 | 15610895 |
MESH:D007889 |
Leiomyoma |
|
Curcumin |
4.01 | 18555241 |
MESH:D007938 |
Leukemia |
|
1L-6-hydroxymethyl-chiro-inositol 2(R)-2-O-methyl-3-O-octadecylcarbonate |
16.17 | 12970779 |
MESH:D007938 |
Leukemia |
|
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one |
16.17 | 12970779 |
MESH:D007938 |
Leukemia |
|
Curcumin |
16.17 | 18462866 |
MESH:D007938 |
Leukemia |
|
SN50 peptide |
16.17 | 12970779 |
MESH:D007938 |
Leukemia |
|
Tretinoin |
16.17 | 17143497 |
MESH:D015459 |
Leukemia-Lymphoma, Adult T-Cell |
|
Curcumin |
3.66 | 16106398 |
MESH:D007948 |
Leukemia, Monocytic, Acute |
|
PD 98059 |
10.07 | 16972261 |
MESH:D007948 |
Leukemia, Monocytic, Acute |
|
U 0126 |
10.07 | 16972261 |
MESH:D007951 |
Leukemia, Myeloid |
|
Tretinoin |
3.15 | 16482212 19285840 16932348 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Tretinoin |
1.96 | 19850784 17596541 16294345 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
Tretinoin |
2.73 | 17217047 17301526 17712046 19225113 19035177 16823087 17107899 16331271 17339181 12679006 19642359 15748426 16891316 16935935 17368321 17506722 9834237 17649720 17294898 16766008 19075265 16788101 16140955 19029980 17361223 |
MESH:D015458 |
Leukemia, T-Cell |
|
Curcumin |
4.18 | 16106398 |
MESH:D017880 |
Limb Deformities, Congenital |
|
Tretinoin |
2.86 | 9224671 |
MESH:D008064 |
Lipidoses |
|
Chlorpromazine |
4.30 | 15342952 17567588 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Curcumin |
4.21 | 18705752 17355460 18006644 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
pirinixic acid |
4.21 | 15474484 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Sirolimus |
4.21 | 17050028 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tretinoin |
4.21 | 18397230 16248980 |
MESH:D008107 |
Liver Diseases |
|
Acetaminophen |
5.58 | 16611625 16610002 12969438 19784758 19014921 19460945 12587719 11587558 |
MESH:D008107 |
Liver Diseases |
|
Chlorpromazine |
5.58 | 14986274 |
MESH:D008107 |
Liver Diseases |
|
Curcumin |
5.58 | 16956363 |
MESH:D017114 |
Liver Failure, Acute |
|
Acetaminophen |
2.70 | 17185352 16871587 |
MESH:D008113 |
Liver Neoplasms |
|
2,6-dinitrotoluene |
8.55 | 7678174 |
MESH:D008113 |
Liver Neoplasms |
|
Dehydroepiandrosterone |
8.55 | 18709148 |
MESH:D008113 |
Liver Neoplasms |
|
dicyclanil |
8.55 | 20118626 |
MESH:D008113 |
Liver Neoplasms |
|
pirinixic acid |
8.55 | 20007298 16377806 15890375 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
2,6-dinitrotoluene |
5.05 | 2876786 2876784 6135515 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Dehydroepiandrosterone |
5.05 | 8603461 |
MESH:D008175 |
Lung Neoplasms |
|
alitretinoin |
3.34 | 16413115 |
MESH:D008175 |
Lung Neoplasms |
|
Curcumin |
3.34 | 19359593 18462866 16243823 |
MESH:D008175 |
Lung Neoplasms |
|
deguelin |
3.34 | 19336726 16288123 |
MESH:D008223 |
Lymphoma |
|
Curcumin |
3.14 | 18462866 |
MESH:D016399 |
Lymphoma, T-Cell |
|
Curcumin |
4.10 | 16173963 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
celecoxib |
5.62 | 12104042 19196722 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Dehydroepiandrosterone |
5.62 | 16457693 |
MESH:D008527 |
Medulloblastoma |
|
Tretinoin |
2.51 | 17453147 |
MESH:D008545 |
Melanoma |
|
2-methoxyestradiol-3,17-bis-O,O-sulfamate |
8.28 | 14970876 |
MESH:D008545 |
Melanoma |
|
Carmustine |
8.28 | 12393984 |
MESH:D008545 |
Melanoma |
|
Curcumin |
8.28 | 18462866 17885582 |
MESH:D008545 |
Melanoma |
|
Sirolimus |
8.28 | 19282848 |
MESH:D008545 |
Melanoma |
|
Tretinoin |
8.28 | 16752155 |
MESH:D008546 |
Melanoma, Experimental |
|
Acetaminophen |
2.97 | 19513568 |
MESH:D008569 |
Memory Disorders |
|
Curcumin |
3.58 | 17263510 |
MESH:D008591 |
Meningomyelocele |
|
Tretinoin |
3.83 | 16940565 |
MESH:D001523 |
Mental Disorders |
|
Chlorpromazine |
7.04 | 16856516 |
MESH:D001523 |
Mental Disorders |
|
Phosphates |
7.04 | 12686366 |
MESH:D008664 |
Metal Metabolism, Inborn Errors |
|
Cyclosporine |
4.17 | 16801185 |
MESH:D009062 |
Mouth Neoplasms |
|
Sirolimus |
4.23 | 19435901 |
MESH:D009101 |
Multiple Myeloma |
|
celecoxib |
6.43 | 16123214 |
MESH:D009101 |
Multiple Myeloma |
|
Curcumin |
6.43 | 19372569 |
MESH:D009134 |
Muscular Atrophy, Spinal |
|
Curcumin |
4.31 | 17962980 |
MESH:D009135 |
Muscular Diseases |
|
pirinixic acid |
2.91 | 16239165 |
MESH:D009175 |
Mycoplasma Infections |
|
Chlorpromazine |
5.38 | 10773494 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Tretinoin |
2.70 | 17596541 |
MESH:D009203 |
Myocardial Infarction |
|
pirinixic acid |
1.86 | 19151258 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
pirinixic acid |
2.47 | 16411023 |
MESH:D009336 |
Necrosis |
|
2,6-dinitrotoluene |
3.26 | 18551238 7678174 |
MESH:D009361 |
Neoplasm Invasiveness |
|
Curcumin |
3.79 | 18495463 |
MESH:D009369 |
Neoplasms |
|
2-methoxyestradiol-3,17-O,O-bis(sulfamate) |
12.21 | 18630502 19156141 18841154 |
MESH:D009369 |
Neoplasms |
|
alitretinoin |
12.21 | 16946489 |
MESH:D009369 |
Neoplasms |
|
deguelin |
12.21 | 17764071 |
MESH:D009369 |
Neoplasms |
|
pirinixic acid |
12.21 | 17405874 |
MESH:D009369 |
Neoplasms |
|
Tretinoin |
12.21 | 16946489 16594593 |
MESH:D009376 |
Neoplasms, Hormone-Dependent |
|
celecoxib |
9.31 | 19196722 |
MESH:D009376 |
Neoplasms, Hormone-Dependent |
|
Curcumin |
9.31 | 12497104 |
MESH:D009389 |
Neovascularization, Pathologic |
|
2-methoxyestradiol-3,17-bis-O,O-sulfamate |
9.44 | 17426705 |
MESH:D009389 |
Neovascularization, Pathologic |
|
parthenolide |
9.44 | 16921510 |
MESH:D009402 |
Nephrosis, Lipoid |
|
Cyclosporine |
3.82 | 17954296 |
MESH:D009404 |
Nephrotic Syndrome |
|
Cyclosporine |
2.77 | 19348381 18481113 |
MESH:D009421 |
Nervous System Malformations |
|
Tretinoin |
3.20 | 9125849 |
MESH:D009423 |
Nervous System Neoplasms |
|
Curcumin |
5.01 | 18462866 |
MESH:D009436 |
Neural Tube Defects |
|
Tretinoin |
2.64 | 9142499 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Acetaminophen |
2.37 | 18514411 |
MESH:D009765 |
Obesity |
|
Curcumin |
3.96 | 19297423 |
MESH:D009765 |
Obesity |
|
pirinixic acid |
3.96 | 20558911 |
MESH:D009784 |
Occupational Diseases |
|
2,6-dinitrotoluene |
2.90 | 16049721 |
MESH:D010024 |
Osteoporosis |
|
Curcumin |
3.07 | 18719352 |
MESH:D015663 |
Osteoporosis, Postmenopausal |
|
Dehydroepiandrosterone |
4.47 | 16397352 |
MESH:D010051 |
Ovarian Neoplasms |
|
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one |
9.45 | 16211241 |
MESH:D010051 |
Ovarian Neoplasms |
|
Curcumin |
9.45 | 19020741 18462866 |
MESH:D010051 |
Ovarian Neoplasms |
|
Tretinoin |
9.45 | 16936753 |
MESH:D010051 |
Ovarian Neoplasms |
|
U 0126 |
9.45 | 16211241 |
MESH:D010146 |
Pain |
|
Acetaminophen |
4.96 | 16870215 |
MESH:D010146 |
Pain |
|
Tretinoin |
4.96 | 16870215 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Curcumin |
4.57 | 17440100 19401701 19196508 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Tretinoin |
4.57 | 15976015 |
MESH:D010300 |
Parkinson Disease |
|
Sirolimus |
3.49 | 19682553 |
MESH:D017499 |
Porokeratosis |
|
alitretinoin |
5.38 | 16144296 |
MESH:D011230 |
Precancerous Conditions |
|
Cyclosporine |
2.71 | 12371664 |
MESH:D011471 |
Prostatic Neoplasms |
|
2-methoxyestradiol-3,17-O,O-bis(sulfamate) |
2.53 | 18985042 18026194 |
MESH:D011471 |
Prostatic Neoplasms |
|
celecoxib |
2.53 | 17908994 15570007 |
MESH:D011471 |
Prostatic Neoplasms |
|
Curcumin |
2.53 | 18769126 11398177 10851300 18226269 18156803 12497104 15129424 |
MESH:D011471 |
Prostatic Neoplasms |
|
parthenolide |
2.53 | 16921510 |
MESH:D011507 |
Proteinuria |
|
Tretinoin |
3.05 | 16636307 |
MESH:D011565 |
Psoriasis |
|
Cyclosporine |
5.64 | 16882103 |
MESH:D011565 |
Psoriasis |
|
tazarotene |
5.64 | 15989518 16605289 |
MESH:D011625 |
Pterygium |
|
Tretinoin |
4.18 | 16723453 |
MESH:D011656 |
Pulmonary Emphysema |
|
Curcumin |
3.99 | 19168576 |
MESH:D015427 |
Reperfusion Injury |
|
pirinixic acid |
2.06 | 19058328 |
MESH:D012128 |
Respiratory Distress Syndrome, Adult |
|
Curcumin |
3.47 | 18379247 10666014 |
MESH:D012175 |
Retinoblastoma |
|
SN50 peptide |
5.88 | 12466137 |
MESH:D012208 |
Rhabdomyosarcoma |
|
Tretinoin |
3.54 | 16283617 16116481 |
MESH:D012509 |
Sarcoma |
|
Curcumin |
3.59 | 18462866 |
MESH:D012640 |
Seizures |
|
2,6-dinitrotoluene |
2.13 | 18551238 |
MESH:D018805 |
Sepsis |
|
Curcumin |
3.57 | 18389075 |
MESH:D012878 |
Skin Neoplasms |
|
deguelin |
5.27 | 16041863 |
MESH:D012878 |
Skin Neoplasms |
|
Tretinoin |
5.27 | 16467112 |
MESH:D013274 |
Stomach Neoplasms |
|
celecoxib |
2.75 | 15609394 |
MESH:D013274 |
Stomach Neoplasms |
|
Tretinoin |
2.75 | 17261132 |
MESH:D013276 |
Stomach Ulcer |
|
Curcumin |
2.98 | 19188055 16631530 |
MESH:D013964 |
Thyroid Neoplasms |
|
Tretinoin |
2.56 | 16026305 17045167 |
MESH:D014062 |
Tongue Neoplasms |
|
Tretinoin |
3.25 | 16051514 |
MESH:D014376 |
Tuberculosis |
|
Tretinoin |
2.82 | 16040207 |
MESH:D014402 |
Tuberous Sclerosis |
|
Sirolimus |
4.99 | 21115397 18495876 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
2,6-dinitrotoluene |
4.31 | 16049721 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Curcumin |
4.31 | 18593936 |
MESH:D014565 |
Urogenital Neoplasms |
|
Curcumin |
4.65 | 18462866 |
MESH:D014571 |
Urologic Neoplasms |
|
2,6-dinitrotoluene |
3.71 | 10091137 |
MESH:D014581 |
Urticaria |
|
Acetaminophen |
2.42 | 10982225 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
Tretinoin |
3.15 | 16129372 |
MESH:D014594 |
Uterine Neoplasms |
|
celecoxib |
4.51 | 18645019 |
MESH:D014604 |
Uveal Neoplasms |
|
Tretinoin |
3.99 | 16752155 |
MESH:D014605 |
Uveitis |
|
Cyclosporine |
10.01 | 1336536 |
MESH:D014605 |
Uveitis |
|
Sirolimus |
10.01 | 1336536 |
MESH:D014820 |
Vitiligo |
|
Tretinoin |
3.48 | 16761959 |
MESH:D009396 |
Wilms Tumor |
|
Tretinoin |
3.45 | 16287080 |
MESH:D014985 |
Xerophthalmia |
|
Cyclosporine |
3.82 | 17120751 |